Representative FOLR1 staining from breast cancer subtypes.
- Brian M. Necela (224867)
- Jennifer A. Crozier (713436)
- Cathy A. Andorfer (713437)
- Laura Lewis-Tuffin (713438)
- Jennifer M. Kachergus (479039)
- Xochiquetzal J. Geiger (488829)
- Krishna R. Kalari (228899)
- Daniel J. Serie (162985)
- Zhifu Sun (60356)
- Alvaro Moreno Aspita (713439)
- Daniel J. O’Shannessy (713440)
- Julia D. Maltzman (713441)
- Ann E. McCullough (117054)
- Barbara A. Pockaj (713442)
- Heather E. Cunliffe (117051)
- Karla V. Ballman (271831)
- E. Aubrey Thompson (224877)
- Edith A. Perez (228921)
Publication date
March 2015
DOIAbstract
<p>(A) benign breast tissue (B9) with negative staining (IHC score 0), (B) estrogen receptor positive invasive ductal carcinoma (ER+IDC) with negative staining (IHC score 0), (C) estrogen receptor positive invasive lobular carcinoma (ER+ILC) with negative staining (IHC score 0), (D) human epidermal growth factor receptor positive (HER2+) with strong 3+ staining (left core) and weak 1+ staining (middle/right cores), and (E) triple negative (TNBC) tumors with strong 3+ staining (left core) and moderate 2+ staining (middle/right cores).</p
Add to ORKG